← All medicines
Qdenga powder and solvent for solution for injection
Licence EU/1/22/1699/001 · Unknown
- Licence holder
- Takeda Pharmaceuticals International AG Ireland Branch (all products →)
- Active substances
- Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated, Dengue virus, serotype 2, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 3, surface proteins, live, attenuated, Dengue virus, serotype 2, expressing Dengue virus, serotype 4, surface proteins, live, attenuated
- Dosage form
- Powder and solvent for solution for injection
- Route of administration
- Subcutaneous use
- ATC codes
- J07B, J07BX04
- First authorised
- 05/12/2022
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.